Skip to Main Content

Advertisement

Skip Nav Destination

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias

Blood (2010) 116 (23): 4783–4785.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement